Tag: biodefense

Pandora Report 4.29.2016

by spopescu, posted in Pandora Report

TGIF- We’ve got your weekly dose of biodefense and much more in this edition of the Pandora Report! Kurdish Peshmerga soldiers are saying that recent ISIS attacks have involved chemical weapons. Heads up- you may want to avoid a spiced herbal tea commonly sold at CVS due to a potential contamination with Salmonella. Check out a new study on biodiversity in swine flu and the potential for spillover.  Monday, April 25, 2016 was World Malaria Day! Lastly, here’s a chuckle to help start your weekend.

2016 Survey on U.S. Role in Global Health
A recent survey of Americans performed by the Kaiser Family Foundation addressed the public perception, knowledge, and attitude regarding the role of the U.S. in global health. The survey addressed topics like American awareness of Zika virus and the health issues that are most urgently facing developing countries. The survey found that a “majority of the public wants the U.S. to take either the leading role or a major role in trying to solve international problems generally, as well as in improving health for people in developing countries specifically.” Interestingly, the importance of improving health for developing countries was not ranked as a top priority like protecting human rights, etc. “Seven in ten Americans believe that the current level of U.S. spending on health in developing countries is too little or about right, yet the public is somewhat skeptical about the ability of more spending to lead to progress, with more than half saying that spending more money will not lead to meaningful progress. Republicans and independents are more skeptical than Democrats, and these partisan differences have increased over time. Another notable trend is the decreasing visibility of U.S. efforts to improve health in developing countries; just over a third of the public says they have heard “a lot” or “some” about these efforts in the past 12 months, a decrease of 21 percentage points since 2010.” The survey also found that while Americans believe the U.S. should help women in Zika-affected countries, there was a divide regarding involvement in their family planning and preventative health measures.

GMU Biodefense Alum Awarded Mirzayan Science & Technology Fellowship
Congrats to GMU Biodefense alum, Dr. David Bolduc, on being named a Christine Mirzayan Science and Technology Policy Graduate Fellow! David graduated from GMU with a PhD in Biodefense in 2011 and doctoral work focused on the threats and mechanisms of chemical, biological, radiological and nuclear (CBRN) agents and CBRN proliferation issues such as treaties, histories and the managing of related mass casualty incidences. David is currently a Principal Investigator at the Armed Forces Radiobiology Research Institute. The Mirzayan Fellowship is a very prestigious award – as a program of the National Academies, it is designed to provide mentorship and professional development opportunities to early-career leaders in the field of science and technology policymaking.

Global Health & Military Expenditure 2013_numbers_subregions_2
Last week we discussed the financing of global health versus military.  There was a recent publication by Sipri (Stockholm International Peace Research Institute) that looked at global military expenditure versus health expenditure (in 2015, it was $1676 billion or about 2.3% of the world’s Gross Domestic Product). They utilized the WHO’s recent estimates of government health expenditure as a share of GDP. They reviewed 2013 data and found that “governments worldwide spent just over two and a half times as much on health than on the military in 2013: 5.9% of global GDP went to public health spending, compared with 2.3% for the military.” Here’s the interesting part – it varied regionally. While the U.S. spends a lot on military, healthcare expenditure is still very high. Western and Central Europe spent 7.8% of their GDP on health and 1.5% on military. The Middle East spent 4.6% of their GDP on military versus 3.0% on health expenditures. The study also looks at reallocation of military spending and what that may translate to regarding the UN’s Sustainable Development Goals (SDGs). “Reallocating only around 10% of world military spending would thus be enough to achieve major progress on some key SDGs, supposing that such funds could be effectively channelled towards these goals and that major obstacles, such as corruption and conflict, could be overcome.”

Did Newcastle Disease Virus Sneak Out of the Lab?
Newcastle disease virus (NDV) is a highly infectious disease that impacts domestic poultry and other birds. Virulent NDV strains have been endemic in poultry throughout Asia, Africa, and some countries within South America. Current outbreaks continue to cause food safety and agricultural issue. In the 1940s, the first NDV panzootic occurred, specifically genotypes II, III, and IV. Other genotypes have continued to circulate and cause outbreaks. A recent study performed a complete genomic sequence of contemporary isolates from China, Egypt, and India. Researchers performed genetic analysis to distinguish historical isolates (the outbreak from the 1940s) from currently circulating genotypes (V, VI, VII, and XII through XVIII). Through their work, they found that isolates of genotypes II and IX (which are not normally circulating viruses in the environment) were found to be identical to the historical viruses that were isolated in the 1940s. “The low rates of change for these virulent viruses (7.05 × 10−5 and 2.05 × 10−5 per year, respectively) and the minimal genetic distances existing between these and historical viruses (0.3 to 1.2%) of the same genotypes indicate an unnatural origin.” The virulent strains isolated during the 1940s have been used in labs and research studies. Researchers noted that it is highly unlikely these viruses remained viable in the environment for over sixty years, which means its very possible (and scary…) that the source of these viral samples, taken from poultry and wild birds, may in fact be from a laboratory. So now we have to wonder…how did these specific virulent viral isolates find their way out of laboratories and into nature?

Is Open Science the Secret Weapon Against Zika and Future Pandemics?
Gene editing tools like CRISPR-Cas9 have the potential to combat diseases like HIV and malaria, but there’s also a potential dual-use for these technologies that is much more sinister. The price of laboratory equipment for some synthetic biology experiments is dwindling and many are becoming concerned about potential for misuse. Should science be left open and researchers ultimately allowed to make the call about potential dual-use or should scientific work/publications be regulated to avoid publications of research that could be used to build a biological weapon? Some are saying that the best way to combat global issues is through global cooperation and communication and thus, open-source information. Should Zika be the first in the test subjects of open science and its application in the global health security toolbox? Many have argued that if a research project is receiving public funding, it should be open sourced (including the data). Would this have helped the Ebola outbreak? “When Ebola was raging through West Africa in the summer of 2014, a group at the Broad Institute in Cambridge, Mass. published open repository sequence data for 99 Ebola genomes taken from patients in Sierra Leone’s Kenema government hospital. This open sourcing of critical scientific data was the second instance in the outbreak. A team of international researchers had initially published three genomes from patients in Guinea in April. For the next three months, no more genomic data was released to the public data repositories that had become the go-to source for scientists studying Ebola. The silence puzzled many prominent scientists. A formidable array of genomic sequencing technology was aimed squarely at the virus. Yet the data was not shared.” Since this outbreak, many have pushed more for open science, especially in the wake of a global outbreak like Zika.

The Other Side of the Spectrum – How Genetic Editing Became a National Security Threat
You may recall in February, Director of National Intelligence, James R. Clapper, stated in his World Wide Threat Assessment testimony that gene editing had become a global danger and should be considered a weapon of mass destruction. The history of genetic research has seen a burst of developments since the discovery of the double helix in 1953. CRISPR-Cas9 is the newest in the genetic engineering arsenal…and at at a fraction of the historical price. If it were only so simple as to do away with malaria by genetically modifying mosquitoes to avoid carrying the parasite. Alas, the realities are a bit darker. The truth is that genome editing of wildlife can alter entire ecosystems, not to mention the risk for accidents and negligence, which is a very real possibility. Those concerns aren’t even touching on the frightening potential for biological weapons. “Gene editing techniques could produce forms of diseases that barely resemble their naturally occurring counterparts. Such engineered pathogens could sicken or even kill hundreds of thousands of people. Armed with the proper genetic sequences, states or bioterrorists could employ genome editing to create highly virulent pathogens for use in such attacks. They could, for example, change a less dangerous, non-pathogenic strain of anthrax into a highly virulent form by altering the genome, or recreate pathogens such as the deadly smallpox virus, which was eradicated in the wild in 1980. Or they could develop specific weapons that target either individuals or even entire races: With the right manipulations, a pathogen could be made to have greater invasiveness or virulence in a target population.” So where do we go from here? With no governance of do-it-yourself facilitates, no training for the at-home gene editing experimenters, and endless debate about the dangers of gain-of-function research, what is being done? Many are saying UN Resolution 1540 should be strengthened to consider this technology and the Dual-Use Research of Concern (DURC) policy shouldn’t just apply to research funded by the government, but also small labs and individuals. With the notion of open science and DURC still up for debate, the stakes will only get higher as global outbreaks, like Zika, continue to burn through countries.

Why We Should Be Afraid of Yellow Fever
Angola is getting hit hard by yellow fever and the vaccine shortages only amplified the outbreak. With all eyes on Zika and a century since Rio saw its last case of yellow fever, where’s the link? Global supplies of yellow fever vaccines are pretty much depleted and BioManguinhos/FioCruz in Rio (one of four…yes four… yellow fever vaccine producers in the world) is having production problems. All available vaccines are being rushed to Angola and cases are spilling over into the DRC, Mauritania, and Kenya. Here’s more – “What most people don’t know is that there are a lot of Angolans coming every year to Brazil, and the more who arrive here unvaccinated, but have been exposed to yellow fever in Africa and may be carrying the virus, the greater the risk that they will infect Rio mosquitoes, allowing them to transmit yellow fever to residents and tourists.” Brazil is already waging a massive war against Zika. Add in yellow fever and it’ll be like adding a gallon of gasoline to a house fire. Mosquito control is imperative and now we’re paying the costs of historically lackadaisical efforts.

Zika Updates
The WHO announced that the number of Zika virus cases is dropping in Brazil. A recent study reports that dengue virus antibodies enhance Zika virus infection. Researchers suggest that pre-existing dengue immunity will enhance a Zika infection in vivo and can increase the severity of disease. Many are calling for more research to be done regarding the relationships between Zika and dengue infections. You can also find a timeline of Zika virus here. There are growing concerns regarding blood donations as Zika spreads internationally. The Canadian Blood service noted that new rules to protect against Zika transmission are putting stress on the blood supply. A new study looks at the impact of Zika and the challenges we many face due to the increasing frequency of viral outbreaks. As of April 27, 2016, there were 426 travel-associated cases in the U.S.

Rewiring Outbreak Preparedness and Response
Let’s take more of a deep-dive into why we should apply U.S. biodefense practices to managing and preparing for outbreaks. Hoyt and Hatchett emphasized why we should learn from American biodefense strategies to better fight infectious disease outbreak. “SARS was responsible for 800 deaths but cost $40 billion globally and Ebola has cost West African economies $6 billion plus an additional $4.3 billion in international contributions. Now, consider the cost of developing a vaccine. Hoyt and Hatchett point out that at the most expensive point, it can cost $1.8 billion to develop a vaccine (others argue that is it much closer to $500 million).”

Stories You May Have Missed:

  • Neurological Problems in Ebola Survivors – a recent NIH study found that nearly all Liberian Ebola survivors reported neurological symptoms following their recovery. Symptoms were noted to have persisted for over a year, including headaches, difficulty walking, overall muscle weakness, loss of memory, and depression. Hallucinations during treatment in Ebola treatment units was prevalent in 25% of patients, with 4% having persistent hallucinations at follow up.
  • Ebola in America: Epidemic of Fear – The Center for Strategic & International Studies has put together a video on the fear and U.S. response to Ebola cases in the U.S. and in West Africa. The video discusses stigma and how Ebola was experienced in the Fall of 2014.
  • Biodefense World Summit – The 2016 event will be hosted in Baltimore, MD on June 27-30, 2016. The Knowledge Foundation’s Second Annual Biodefense World Summit brings together leaders from government, academia, and industry for compelling discussions and comprehensive coverage on pathogen detection, sample prep technologies, point-of-care, and biosurveillance. Across the four-track event, attendees can expect exceptional networking opportunities in the exhibit hall, across panel discussions, and shared case studies with members of the biodefense community from technology providers to policy makers

 

Pandora Report 4.15.2016

by spopescu, posted in Pandora Report

It’s been a big week in the world of biodefense – today is International Biomedical Laboratory Science Day! Biomedical Laboratory Scientists work hard to ensure procedures and patient care happens in a safe environment and that patient safety comes first! April 10th marked the anniversary of the Biological Weapons Convention opening for signature in London, Moscow, and Washington in 1972. The U.S. Geological Society also just released evidence that Alaska remains a “hot spot” for avian influenza to enter North America.

GMU Participation in UNSCR 1540 Civil Society Forum
IMG_3260This week our GMU Biodefense Professor and Graduate Program Director, Dr. Koblentz, participated in the UN’s 1540 Civil Society Forum – A Dialogue with Academia and Civil Society. Dr. Koblentz presented a paper on the role of academia in implementing and strengthening Resolution 1540, as well as moderating a panel regarding academic outreach. Resolution 1540 (2004) “imposes binding obligations on all States to adopt legislation to prevent the proliferation of nuclear, chemical and biological weapons, and their means of delivery, and  establish appropriate domestic controls over related materials to prevent their illicit trafficking. It also encourages enhanced international cooperation on such efforts.” Dr. Koblentz’s  work with the UNSCR 1540 Civil Society Forum addresses the evolution of WMD proliferation threats related to non-state actors, 1540 obligations that pertain to the academic community, and the importance of academia in these efforts. The forum also focussed on how to enhance review and analysis of 1540 implementation via communication between civil society, national governments, and the 1540 Committee.

Written Testimony for April 14 Senate Committee on Homeland Security & Governmental Affairs Hearing – “The Federal Perspective on the State of Our Nation’s Biodefense”
You can now catch up on the written testimony from this hearing on biodefense within the U.S. Pointing to the evolution of threats to include more emerging infectious diseases and the role of DHS in biodefense, this overview gives insight into the current biodefense situation within the U.S. The hearing addressed the National Biosurveillance Integration Center (NBIC), BioWatch Program, Public Health Emergency Medical Countermeasures Enterprise, and state and local responder engagement. “In the wake of these growing threats, the Department of Homeland Security (DHS) remains fully engaged and proactive in attempting to characterize the threat, providing warning of emerging and imminent threats, and coordinating whole of government response. During the most recent Ebola Virus Disease outbreak in West Africa, DHS provided intelligence analysis to the interagency, state and local governments, and first responders, and it directed research to better characterize the threat and fill gaps in public health and operational responses.” You can read the testimony before the Committee on Homeland Security and Governmental Affairs, “The Nation Faces Multiple Challenges Building and Maintaining Biodefense and Biosurveillance” here.

Preparing for the Next Zika
Kendall Hoyt and Richard Hatchett are tackling the struggle of U.S. preparedness efforts for future infectious disease outbreaks. “The development of new biomedical countermeasures—vaccines, therapies and diagnostic—requires the coordination of a wide number of institutional and industry actors to succeed. We argue here that international efforts to develop countermeasures for emerging infectious diseases should build on lessons learned from US programs to develop closely related biodefense products.” While the WHO declaration of Zika virus as a public health emergency has pushed for the rapid development of a vaccine, Hoyt and Hatchett highlight the empirical delay that comes with vaccine development. Overall, they emphasize that lessons from the U.S. biodefense program should inform international efforts to build and strengthen medical countermeasures for emerging infectious diseases. If you enjoyed their article, you can also hear from the experts, in person, at GMU’s Pandemics, Bioterrorism, and Global Health Security summer program. Dr. Hoyt will be one of the instructors for our professional education course this summer (information will be made available shortly), so don’t miss out on getting to chat with experts in the field about all things biodefense.

GMU SPGIA PhD Information Session
Considering a PhD? Check out GMU’S School of Policy, Government, and International Affairs PhD Informational Session on Thursday, April 21, 7-8:30pm at our Arlington Campus, Founders Hall, Room 126. Dr. Koblentz will be discussing the Biodefense program and available to answer questions!

Lab Safety Tracking Website – Improving Select Agent Lab Oversight
In response to ongoing scrutiny and biosafety failures, federal regulators have launched a new website that will allow them to track their progress “improving oversight of safety and security at facilities working with bioterror pathogens such as anthrax and Ebola.” While still a work in progress, many are pointing to this site being a step in the right direction towards transparency. The CDC released their Federal Select Agent Program (FSAP) report card to look more closely at biosafety and security issues surrounding this work. Unfortunately, some note that the report card still fails to meet the requested details on labs violations and incidents at specific labs. The increased scrutiny and attention to lab safety failures has brought attention from the White House, initiating a push for more transparency regarding the research and incidents in labs working with bioterror agents.

HIV Fights Off CRISPR
Just when you thought CRISPR-Cas9 could do just about anything, HIV brings its A-game. Since its creation, many researchers have attempted to use CRISPR to combat HIV. Unfortunately, the virus has been skilled at fending off these efforts. “The very act of editing—involving snipping at the virus’s genome—may introduce mutations that help it to resist attack.” There are a handful of strategies for using CRISPR gene editing technologies against HIV – editing the T helper cells to avoid the virus from getting in or aiding the T cells with the capabilities to seek out and destroy any HIV that infects them. “When HIV infects a T cell, its genome is inserted into the cell’s DNA and hijacks its DNA-replicating machinery to churn out more copies of the virus. But a T cell equipped with a DNA-shearing enzyme called Cas9, together with customized pieces of RNA that guide the enzyme to a particular sequence in the HIV genome, could find, cut and cripple the invader’s genome.” Sounds like a good plan, right? Unfortunately, a team from McGill University found that the newly equipped T cells were, within two weeks, churning out virus particle copies that had avoided the CRISPR attack. The team performed DNA sequencing to get a closer look at what exactly what going on – they found that the virus had actually “developed mutations near the sequence that the CRISPR-Cas9 enzyme that been programmed to cut.” The team believes that it’s not actually the copying error-caused mutations that helped beat CRISPR, but rather that things went wrong when Cas9 cut the viral DNA. A team at the University of Amsterdam experienced similar results and both groups agree that this problem can be overcome and there is still a possibility for a CRISPR-Cas9-based HIV treatment.

All Things Zika
On 4/13, the CDC formally concluded that Zika virus causes microcephaly and other birth defects. Zika virus may now also be tied to another brain disease. The American Academy of Neurology published a report regarding a study that was released on April 10th, in which “Zika virus may be associated with an autoimmune disorder that attacks the brain’s myelin similar to multiple sclerosis”. While it’s a small study, these findings point to the neurological effects Zika virus is capable of causing and the need for further research. Experts are warning governments in Latin American to “fill a shortfall of investment to prevent further human tragedies” despite economists denying that there will be major impact from the virus. These experts are pointing to the already weakened economies that are plagued with “chronic underinvestment in water and sanitation”, which can aid in the spread of such diseases. On Monday, April 11th, the White House said that the released funds for Zika virus won’t be enough to combat the growing threat. Dr. Fauci of the National Institute of Allergy and Infectious Diseases highlighted that the more information that is gathered on Zika virus, the more worrisome it becomes. “One big problem, Fauci said, is that pharmaceutical companies could be reluctant to work with the federal government if they don’t have confidence that there will be a stable source of money.” A recent study published in PLOS Neglected Tropical Diseases, suggests that the virus may have been brought to Latin America via the 6th World Sprint Championship Canoe Race in August 2014.  USAID has put out a call for problem solvers to share groundbreaking ideas to help combat Zika virus. The Combating Zika and Future Threats Grand Challenge will invest up to $30 million in solutions. As of April 13th, the CDC has reported 358 travel-associated and 7 sexually transmitted cases of Zika in the U.S. You can also get the full WHO Zika situation report here.

Predicting and Evaluating the Epidemic Trend of Ebola in the 2014/2015 Outbreak and the Effects of Intervention Measures Screen Shot 2016-04-11 at 9.41.51 AM
Researchers developed several transmission models for Ebola to predict epidemic trends and evaluate just how efficient and effective the intervention methods were following the 2014 outbreak. Accounting for effective vaccination rates, a basic reproductive number as an intermediate variable, and fluctuations of diseases transmission based on a SIR model, this study evaluates the effects of control and prevention measures. “Measures that reduced the spread of EVD included: early diagnosis, treatment in isolation, isolating/monitoring close contacts, timely corpse removal, post-recovery condom use, and preventing or quarantining imported cases. EVD may re-emerge within two decades without control and prevention measures.”

Stories You May Have Missed:

  • National Science Advisory Board for Biosecurity (NSAAB) Meeting – Don’t miss out on the NSAAB meeting on May 24, 2016! Agenda items include: (1) Finalization of NSABB findings and recommendations on a conceptual approach to evaluating proposed gain-of-function (GOF) studies; (2) discussion of next steps for U.S. government policy development regarding GOF studies; and (3) other business of the Board. The meeting will also be webcast here at the time of the event!
  • BMBL Virtual Town Hall and Workshop – The National Academies of Science, Engineering, and Medicine presents an opportunity for stakeholders to provide input for a revision of “Biosafety in Microbiological and Biomedical Laboratories”. This is a virtual town hall that is open for comments from April 4-May 13th. There will also be a workshop on May 12th in Washington, DC that you can register for here.
  • DARPA INTERCEPT Program for Biodefense Countermeasures – The Defense Advanced Research Project Agency (DARPA)’s Biological Technologies Office (BTO) is hosting a Proposers Day for the INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) program. “The goal of the INTERCEPT program is to explore and develop a new therapeutic platform to outpace fast-evolving viral pathogens, based upon virus-based therapeutic particles that interfere with viral infection and co-evolve with viral targets.”
  • Angola Yellow Fever Outbreak – The WHO has reported that as of April 10th, there have been 1,751 suspected cases and 242 deaths associated with the yellow fever outbreak. 582 of the cases were laboratory confirmed, of which 406 were from the Luanda province.

Enjoying your weekly dose of the Pandora Report? Sign up to receive it every week so the fun never ends! 

Pandora Report: 3.25.2016

by spopescu, posted in Pandora Report

Happy Friday! Ready for some global health security news? Down the rabbit hole we go….the FDA has just approved ANTHIM injection, a new treatment for inhalation anthrax in adults and children. Researchers are considering the possibility that the highly virulent E. coli O104:H4 strain that hit Germany in 2011 may have been an intentional act. “The sudden and unexplainable emerging of a fast increasing number of cases and deaths from bloody diarrhea and HUS might have been caused naturally, accidentally, or intentionally,” a Serbian-German research team writes in the European Journal of Public Health Advance Access for April 15.

The Finances of A Pandemic
From SARS to Ebola and now Zika, the growing threat of emerging infectious diseases doesn’t seem to be slowing down. Has this become our new normal? Will we learn from these outbreaks and start putting the resources and support into prevention? “Ebola has infected almost 30,000 people, killed more than 11,000 and cost more than $2 billion in lost output in the three hardest-hit countries. SARS infected 8,000 and killed 800; because it hit richer places, it cost more than $40 billion. Predicting these losses is hard, but a recent report on global health risks puts the expected economic losses from potential pandemics at around $60 billion a year.” So how do we defend against these international security threats? America’s National Academy of Medicine recently made the suggestion that $4.5 billion a year solely dedicated to pandemic preparedness and defense could halt this impending reality. Even more interesting? This estimate accounts to roughly 3% of what “rich countries spend on development aid”, while the world spends about $2 trillion annually on defense.

U.S. Biothreat Defense Inadequate
American response to Ebola and now Zika reveals a startling trend of slow response, inadequate supplies, and poor cooperation and coordination between agencies. Director of National Intelligence, James Clapper states that “Gaps in disease surveillance and reporting, limited health care resources, and other factors contributed to the outpacing of the international community’s response in West Africa,”. The National Biosurveillance Integration Center (NBIC) is one such agency that was developed in 2007 in attempts to “be a hub of information and coordination for federal agencies tracking disease and biological threats”, however it has been frustrated by poor relationships and sharing from other agencies like the CDC. In essence, agencies that are developed for global health security, like NBIC, suffer from poor cooperation that then trickles into their reputation and capabilities in the eyes of their federal partners. “Congress has put forth a potential legislative fix. The CBRNE Defense Act of 2015 would create a new office within DHS, the Chemical, Biological, Radiological, Nuclear, and Explosives Office, which would place both NBIC and BioWatch under integrated new management.” Just as we reported from the Blue Ribbon Study Panel, federal biodefense efforts and resources need to be better organized and developed.

Rare Blood Infection Outbreak
Elizabethkingiam is currently causing dozens of cases in Wisconsin and now a Michigan resident is suffering from the bloodstream infection. The bacteria that causes the infection, Elizabethkingia meningoseptica, is commonly found in soil but has also caused infections in hospitals. Typical infections have resulted in bacteremia and neonatal meningitis related to the gram-negative bacillus, although it is naturally found in soil, fresh water, and salt water. Most of the 54 cases in Wisconsin have been in patients 65 years and older, of which 17 have died. Public health officials are working to identify the source of the outbreak and the links between the Michigan case and those in Wisconsin. The concerning aspects of this rising outbreak is also the difficulty in treating the organism and prevalence of multi-drug resistant organisms in seniors.

Complex Engineering by Violent Non-State Actors
Check out this special issue on complex engineering by violent non-state actors (VSNAs). “Why and how different VNSAs remain low-level and localized or undertake and achieve complex engineering tasks in pursuit of their objectives are at the heart of understanding the threat environment faced by states.” The authors address several terrorist groups like Aum Shinrikyo (the chapter was actually co-authored by GMU Biodefense Alum Benjamin Ash!), Hamas (also co-authored by GMU Biodefense Alum Alena James!), the Provisional Irish Republican Army (PIRA), etc.  “The approach of this collection moves beyond weapons and embraces facilitating or logistical aspects that support the operations and objectives of the various actors”. This special edition, with an introduction by Jez Littlewood, reviews these organizations and their resources and strategies. The authors also consider the attitudes of leadership regarding innovation in detail to assess the role of complex engineering by VSNAs. Through this close look into the VSNA use of complex engineering, further research and preparedness can occur to understand the threats posed by these actors.

All Roads Lead to Zika 
Now that Spring has officially begun, the impending summer rains are right around the corner, and with those – mosquitoes. Many worry about the potential for local transmission in countries where imported cases have already been identified. The US isn’t immune to these concerns as the CDC reports 273 travel-related cases. Dr. Nabel mirrors the sentiments of Sanofi’s global R&D head, Dr. Elias Zherouni, who emphasizes the need for changes in global public health outbreak response. He notes that “we just run from one crisis to another. It’s not an optimal way to respond. Not when the stakes are so high and when so many people can either lose their lives or have their whole lives changed because of one five-day infection. That’s no way to protect the world’s population. We have to step back and we have to say, ‘Is there a more systematic way to gather the intelligence that we have about these viruses, recognize where they stand in terms of the threat level, and then develop a systematic program where, when the next Ebola outbreak occurs, it’s not that we haven’t done anything since the last outbreak, that we’ve actually moved things forward?’ That’s all possible. It’s just that we have not had the collective will to do it.” Panama has also announced their first case of microcephaly linked to Zika virus outside of Brazil. Chris Mooney from The Washington Post discusses why Zika virus, among other diseases, could disproportionally impact America’s poorer populations.  He notes that scientists have found that more mosquitoes are found in lower-income neighborhoods due to persistent trash and abandoned buildings, which creates a ripe environment for standing water and thus mosquito breeding. Researchers found that when compared to wealthier neighborhoods in New Jersey, “poverty was positively correlated with number of [Asian tiger mosquitoes] captured and accounted for over half the variation”. Many are saying that the “U.S. is botching the Zika fight” due to the problems within the FDA and the Agriculture Department regarding turf. “A genetically tweaked mosquito could stop the illness, but regulators won’t test it. Why would that be?” The combination of worrying reasons, like “budgetary concerns and antagonism to genetic engineering among some senior USDA officials”, leave many feeling that instead of getting ahead of the outbreak, “the U.S. is falling behind, solely because of bureaucratic muddle.” On the other hand, on Friday, the WHO rallied for pilot projects on two projects that would involve genetically modified mosquitoes to help stop the spread of Zika virus. In the meantime, the FDA gave emergency approval for a 3-in-1 test for Zika, Chikungunya, and Dengue.

Syria and the Future of the Chemical Weapons Taboo 

Courtesy of E-International Relations
Courtesy of E-International Relations

Brett Edwards and Mattia Cacciatori tackle the responses that the international security community has taken regarding the use of chemical weapons in Syria and the resulting reinforcement of “a long standing prohibition norm.” The authors discuss the characteristics of chemical weapons taboo and and the significance that the international community gives to these weapons. “This alone does not support the claim episode has strengthened the global norm against chemical weapons. In this piece we have highlighted how this is not immediately apparent due to the fact that problem cases tend to be externalized from dominant institutional discourses, often justified in terms of the need to protect the sanctity of the chemical weapon norm, as well as those institution’s which embody the norm – especially the OPCW.” Overall, the more problematic cases, like those of incapacitating chemical agents, will grow to alter the existing foundation of chemical weapons norms if left ignored or unchecked.

New Ebola Flare Up
The west African Ebola outbreak is like a campfire that wasn’t put out properly – everyone thinks the flames are extinguished, but those hidden embers lurking in the ash end up causing a spark that leads to a massive forest fire. A fifth person has died from the recent flare in Guinea. The most recent death occurred in a man 200k from the initial four cases. Prior to this death, a young girl died from the village of Korokpara following her hospitalization in an Ebola treatment facility in Nzerekore. It’s still not clear how this specific surge began, but many worry about the lingering traces of the virus in the eyes, CNS, and bodily fluids. In response to the fifth death, Liberia has partially shut its borders. Emergency meetings are now underway and the WHO is sending specialist teams in to try and stop the outbreak before it grows beyond the 11,300 mortality count. On a positive note, Sierra Leone has gone two incubations periods (42 days) without a case, which means they’re Ebola-free since their last flare up.

GMU SPGIA Gettysburg Trip
GMU students interested in learning more about the battle of Gettysburg- the Center for Security Policy Studies (CSPS) will be hosting an informational session on April 6th from 4:30-6pm in Merten Hall 1203 regarding the April 9th trip! GMU students and staff will walk the battlefield, discussing the factors that caused the battle to unfold as it did. They will also link the battle into larger discussions about the causes of war and grand strategy.  The cost for the trip will be $35.  Bus transportation will be provided, and will pick up participants from both the Fairfax and Arlington campuses.

Stories You May Have Missed:

  • U.N. Sued Over Haiti Cholera Outbreak– starting in October of 2014, Haiti was hit with an intense wave of cholera that is believed to have started with U.N. peacekeepers. “Poor sanitation at a U.N. camp for peacekeepers allowed cholera-contaminated sewage to enter a tributary of Haiti’s largest river, the Artibonite. Within days, hundreds of people downstream, like Jean-Clair Desir and his mother, were falling ill. The disease subsequently spread to the entire country.” The case is currently being reviewed in US courts and the lawsuit was brought forth by the Institute for Justice in Democracy, asking that the U.N. “end cholera by installing a national water and sanitation system; pay reparations to cholera victims and their families; and publicly apologize for bringing cholera to Haiti.”
  • Exploiting the Challenges to Bioweapons Development – Janne E. Nolan discusses GMU Biodefense Professor, Dr. Sonia Ben Ouagrham-Gormley’s book, Barriers to Bioweapons, in regards to the misleading and often exaggerated notion of easy WMD development. Nolan discusses that understanding both the internal and external factors that impact BW program success would allow the international community to “devise better ways to realistically stem BW proliferation”. He notes that “Ben Ouagrham-Gormley’ s book is a fascinating study of the phenomenology of scientific knowledge, providing a compelling analysis of how knowledge is acquired, developed, transmitted, and, at the same time, diluted or lost as a result of organizational, social, economic, political, and ultimately very human factors that vary widely within countries and over time.” You can also access it here: Nolan final
  • Five Outbreaks That Stump Epidemiologists– As much as I’d love to say that all outbreaks are investigated and solved, the truth is that epidemiologists are often left with the nagging of an unresolved case. Outbreaks are squirrelly at best, often challenging even the best teams with confounders and biases. Here are some that have stumped public health teams over the years.
  • Lassa Fever Outbreak– Three people are suspected of having the viral infection after coming into contact with an infected American. The initial case was a medical director of a missionary hospital in Togo, who died last month. While there are conflicting reports of disease confirmation, several sources are saying the three contacts of this initial case have been diagnosed and are under observation. The outbreak in Nigeria and Benin has continued to grow, resulting in CDC travel warnings. In Nigeria there have been 254 cases and Benin has seen 71.

Enjoying your weekly dose of the Pandora Report? Sign up to receive it every week so the fun never ends! 

Pandora Report 3.11.2016

by spopescu, posted in Pandora Report

TGIF! We’ve got loads of global health security updates to keep you busy why you enjoy the warm spring weather. American special forces recently captured the chief ISIS chemical weapons engineer and you may want to avoid Wonderful Co. pistachios for a bit as they’re being linked to a salmonella outbreak.

The Smallpox Battlegrounds – Laboratories and Virtual RealityScreen Shot 2016-03-07 at 10.49.30 AM
Video game fans will be excited to hear about the new Tom Clancy game, The Division, released on March 8th. This isn’t your normal action-packed video game, but rather it has something more sinister about its premise. The Division focusses on a biochem attack involving a take over by a group called the Strategic Homeland Division aka “The Division”. The Division is compromised of sleeper agents that “act independently in the interest of restoring order after a mass event”. Now here’s where it gets spooky, the game’s premise involves a scenario that may give deja vu to many in the biodefense world- Operation Dark Winter. Operation Dark Winter was a June 2001 exercise/senior-level war game put on by the Center for Strategic and International Studies, the Johns Hopkins Center for Civilian Biodefense Studies, the ANSER Institute for Homeland Security, and the Oklahoma City National Memorial Institute for the Prevention of Terrorism. The scenario focussed on the impact and response of a smallpox outbreak coupled with tensions in the Taiwan Straits and additional crises. In a nutshell, the scenario found that “current organizational structures and capabilities are not well suited for the management of a BW attack”, media management would be challenging for the government, containment and infection prevention would present several issues, and we’d pretty much be in a whirlwind of trouble. If you’re more of a purest and The Division doesn’t appeal to you, there’s also The Collapse, which is an internet-based game that lets you simulate a smallpox outbreak. Unlike other games where the player designs the outbreak, this one is from the viewpoint of the patient. You’re patient zero with a weaponized strain of smallpox and your decisions carry with them a world of outcomes involving the spread of the disease and rate of infection. I spent some time playing The Collapse (starting at GMU for sheer irony) and found it to be very detail oriented and enjoyed the decision making components like which pharmacy I would go to, my travel destination, etc. If you’re not much of a gamer, here’s the recent WHO report on the deliberations regarding the destruction of variola virus stocks. To destroy smallpox or not to destroy smallpox, that is the question.

GMU Course Sampler & Open Houses
Looking to study and work with people that share your love of biodefense? Come check out our March 23rd GMU SPGIA Open House at 6:30pm, in Founders Hall, room 126 at our Arlington Campus! Not only will you be able to chat biodefense, but we’ll have an informational session afterward (7pm) with Dr. Koblentz (you can check out the 2/25 one here). Each session allows us to discuss global health security and answer questions related to our program and the growing field of biodefense. Can’t attend in person? Enjoy our 3/23 biodefense breakout session virtually! If you happened to miss our biodefense course sampler from 3/2, check out the recording from Dr. Koblentz’s talk on Biosecurity as a Wicked Problem.

Chinese Admission of False Korean War Allegations Involving US BW Use
Biodefense expert, Milton Leitenberg, discusses the allegations by North Korea, China, and the Soviet Union, that the US used bioweapons during the Korean War. While the Soviet Central Committee declared the allegations fraudulent in 1998, China and North Korea continued to maintain that bioweapons were used. The recent publication by Wu Zhili (previously the director of the Chinese People’s Volunteer Army Health Division during the Korean War) refutes these claims. Published posthumously, Wu’s testimonial is critical in dismantling the claims as he was “critically involved in the Chinese government’s manipulations that produced the Korean War BW allegations.” The initial allegations claimed that the US was testing bioweapons (specifically plague) on native Inuit peoples of Alaska and then was spreading smallpox in North Korea between December 1950- January 1951. The major allegation campaign began on February 22, 1952 though, as “the North Korean Foreign Minister again issued an official statement addressed to the United Nations Secretariat, charging that in January and February the US had made multiple air drops over North Korea, littering the earth with insects infected with the microorganisms that caused plague, cholera, and other diseases.” Leitenberg discusses these allegations and the Soviet admission of being “misled” and their claims that “the accusations against the Americans were fictitious…Soviet workers responsible for participation in the fabrication of the so-called ‘proof’ of the use of bacteriological weapons will receive severe punishment.” He goes on to discuss Wu’s publication and explanation of the tasks that were carried out to further the belief in US bioweapon applications.

Gain of Function Research
Researchers, Dr. Lipsitch, Dr. Relman, and Dr. Ingelsby, have joined together to discuss the realistic future for research that seeks to alter pathogens. Pointing to the National Academy of Sciences (NAS) meeting, they note that it “marks a turning point in a year-and-a-half-long policy process to consider the risks, benefits, oversight, and regulation of experiments that are designed to create influenza and other viruses that are simultaneously highly virulent and readily transmissible by respiratory droplets between mammals.” Focus has traditionally been on the pros and cons of gain-of-function (GOF) projects however, as time passes, a narrowing of concern seems to be focussed on experiments that seek to build chimeric viruses that are highly dangerous and transmissible. They recommend the following policy approach: lift the moratorium on GOFoc, seek international consensus, secure national and international agreement to restrict the performance of GOFoc studies, design a board, establish clear red lines for GOFoc research, and require the purchase by research institutions of specific liability insurance policies. You can also read the interview with the researchers regarding the implications of such research censorships. Dr. Filippa also discusses engineering a super flu here, noting that “the debate is really about risk assessment of this gain of function work and about who should be making those assessments. Should it just be scientists, should it be their institutions, should it be funders, should it be publishers or, much more broadly, should it be regulators, vaccine manufacturers, ethicists? ”

Zika Updates
CDC and NIAID officials are becoming frustrated as they feel Congress is blocking key efforts to fight the outbreak. A recently published report on research priorities to inform public health and medical practice for domestic Zika virus can be found here. The report emphasizes the growing spread of infection and subsequent need for additional research related to transmission, infection during pregnancy, and disease characteristics . The recent WHO stakeholders meeting provided updates on the most urgently needed tools to fight the growing pandemic. The roadmap includes diagnostic tests, inactivated vaccines targeted to childbearing-aged women, and new vector control mechanisms.  As of March 9th, there were 193 confirmed travel-associated Zika cases in the U.S.  A recent study found that 42% of questioned Americans believe the virus has high mortality rates. Aedes mosquitoes are also developing resistance to the go-to insecticide.

7 Sources for Understanding Epidemics
Feeling like all this Zika news has you needing to catch up on your outbreak cliff notes? The Washington Post has put together a nice list of seven books and movies you can enjoy to help ramp up your knowledge regarding the world of pandemics. This list is a great way to understand the different viewpoints of outbreaks and pandemics from social, medical, political, and scientific viewpoints. If you find yourself wanting more, here are some additional recommendations I’m throwing in: Spillover by David Quammen, Pandemic: Tracking Contagions, from Cholera to Ebola and Beyond by Sonia Shah, and The Coming Plague by Laurie Garrett. Feeling like something a little bit more dramatic? Check out Richard Preston’s The Hot Zone or Demon in the Freezer, or the movies Outbreak or World War Z. With the success of Contagion, I’m still hoping Hollywood will continue to back scientifically grounded films about pandemics (between ebola and Zika virus, they’ve got enough material!).

Stories You May Have Missed:

  • Why Are Mosquitoes Just So Good At Spreading Disease? Mosquitoes have been causing outbreaks since the days of ancient Rome and yet we’re still battling them in the fight against Zika, dengue, chikungunya, and more. “According to Janet McAllister, an entomologist with the U.S. Centers for Disease Control and Prevention (CDC), not all mosquitoes are good at transmitting disease, but the ones that are have evolved to live closer to humans.”
  • Global Health Security Agenda– GHSA was launched in 2014 as a multilateral approach to help protect the world from infectious disease threats. Endorsed by the G7, this agenda facilitates a “partnership of nearly 50 nations, international organizations, and non-governmental stakeholders, GHSA is facilitating collaborative, capacity-building efforts to achieve specific and measurable targets around biological threats, while accelerating achievement of the core capacities required by the World Health Organization’s (WHO’s) International Health Regulations (IHR), the World Organization of Animal Health’s (OIE) Performance of Veterinary Services Pathway, and other relevant global health security frameworks.”
  • Fumbling Ebola– The San Francisco-based epidemiology company, Metabiota, is being charged with making several mistakes according to the Associated Press (AP). Recovered communication reveals that the company fueled an already chaotic situation via misdiagnoses, adding to confusion, and poor sample tracking.
  • Guidelines for Ebola Survivor Care– The WHO has published guidelines on the management and care of patients who were previously infected with Ebola. Since there are roughly 10,000 ebola survivors and several have required hospitalization for complications, these recommendations are extremely prudent. The report includes counseling, considerations for special patient populations, and common sequelae and management recommendations.

Enjoying your weekly dose of the Pandora Report? Sign up to receive it every week so the fun never ends! 

Pandora Report: 3.4.2016

by spopescu, posted in Pandora Report

Dirty bombs, Zika virus, and biosecurity in Iraq? That’s just a taste of the biodefense news we’ve got in store for you this week. While norovirus hits the East Coast (thanks, oysters!) and an additional three cases were confirmed in the seven-month-long Listeria outbreak associated with Dole salads, it’s no wonder there’s been work to build a new US food safety system. Next month the CDC will be working with state and local officials to establish plans in the most hard-hit Zika areas.

Assessing America’s Soft Underbelly and The Threat of Agroterrorism
The House Committee on Homeland Security’s Emergency Preparedness, Response, and Communications Subcommittee held a hearing on Friday in which they discussed and reviewed the risk of agroterrorism or natural agro-disasters. Disruption to the agriculture infrastructure and economy could be devastating to the US. Regardless if it’s private or public sectors, preparedness is vital to reduce calamitous damage. “US food and agriculture accounts for roughly one-fifth of the nation’s economic activity, contributed $835 billion to the US gross domestic product in 2014, and is responsible for one out of every 12 US jobs, according to Subcommittee Chairman Martha McSally (R-AZ).” Consider the impact of bovine spongiform encephalopathy (BSE) or Highly Pathogenic Avian Influenza (HPAI) on their respective sectors and country economies. Some of the highlighted vulnerabilities and challenges were insufficient quantity of Foot and Mouth Disease (FMD) vaccine, gaps in US biosecurity, traceability, gaps in detection, data sharing for regulated disease, and more.

Strengthening Biosecurity in Iraq: Development of a National Biorisk Management SystemScreen Shot 2016-03-04 at 10.02.47 AM
GMU Biodefense director and professor, Dr. Gregory Koblentz, and Mahdi al-Jewari, director of the biology department for the Iraqi National Monitoring Authority in the Iraq Ministry of Science of Technology, have joined together to discuss the furthering of Iraqi biosecurity. Mahdi al-Jewari visited GMU in early 2015 to speak on global biorisk management, hosted by the GMU School of Policy, Government, and International Affairs. In their research, Dr. Koblentz and Mr. al-Jewari discuss Iraq’s implementation of its non-proliferation commitments, highlighting that since 2004 “Iraq has taken a series of practical steps to implement its obligations under international non-proliferation treaties to prevent the proliferation of weapons of mass destruction and their means of delivery to states and non-state actors.” The Iraqi National Monitoring Authority, established in 2012, strives to strengthen their biosecurity program through three primary functions: compliance, monitoring of dual-use materials, and capacity building. The National Biorisk Management System has also highlighted four priorities to “counter biological threats: establishing a national pathogen list, building laboratory capacity, developing the capability to conduct joint law enforcement–public health investigations, and establishing a biorisk management law. The NBMC has established sub-committees charged with developing new policies and programs to achieve these four objectives.” While sustainability will be the most challenging hurdle for Iraq, commitment to investments  in infrastructure, IT, biosecurity, and biosurveillance systems can help them overcome these difficulties.

Just How Far Down the Zika Rabbit Hole Are We So Far?
It seems like every week we’re learning new things about Zika virus and how much work needs to be done. I wonder, how far have we made it down the rabbit hole for Zika and how much more do we have to go? While the Aedes mosquito is the reigning king of Zika virus infections, what about animals? The CDC recently released information regarding the concerns over zoonotic cases. Originally discovered in a monkey in the Zika Forest in 1940’s Uganda , the CDC maintains that “at this time, animals do not appear to be involved in the spread” and that there is no evidence of zoonotic transmission. “Nonhuman primates (apes and monkeys) have shown the ability to become infected with Zika virus; but, only a few naturally and experimentally infected monkeys and apes have had any signs of illness at all, and then it was only a mild, transient fever without any other symptoms.” As international public health teams descend upon the outbreak regions, we will surely be learning more about this outbreak. Perhaps the most challenging issue is the dissemination of information, especially in regions of high transmission. University of Arizona Mel & Enid Zuckerman College of Public Health infectious disease professor, Dr. Kacey Ernst, is one of the top vector-borne researchers and she recently explained: “The Zika virus pandemic, thought to be primarily caused by transmission of the virus through Ae. aegypti requires urgent action to determine the role of the virus in neurological sequalea, including microcephaly as well as the relative transmission potential of Ae. albopictus. Given the important role of communities in preventing the proliferation of the peridomestic, anthropophilic Ae. aegypti, communication between the scientific communities and the public must be heightened to ensure timely dissemination of surveillance information. While much of the United States is currently too cold to allow high densities of the primary vector of Zika virus, Ae. aegypti, the growing evidence surrounding the role of sexual transmission in the spread of Zika could imply that outbreaks of disease are possible even when transmission by the mosquito is not. More research is needed to delineate the two modes of transmission and the role that sexual transmission may be playing in the explosive spread of Zika across Latin America and the Caribbean.” In more Zika updates, blood samples from French Polynesia patients with Guillain-Barré syndrome (GBS) during their Zika virus outbreak are revealing the first look into the reality that Zika may actually cause GBS. The CDC is also urging pregnant women to avoid the summer Olympics in Brazil due to the outbreak. The FDA also just issued their Emergency Use Authorization for a Zika diagnostic tool for qualified countries. As of March 2nd, the CDC has reported 153 travel-associated Zika virus cases within the US.

Education Gaps on Dirty Bombs
David Ropeik from Scientific American discusses the impact that poor education and fear regarding dirty bombs can pose during an emergency. “The prospect of such a bomb seems terrifying, but anyone who knows the basic science of radiation biology knows that it wouldn’t cause much health damage, because the dose of radioactivity to which most people might be exposed would be very low. And experts know, based on the 65 year Life Span Study of the survivors of atomic bomb explosions in Japan, that even at extraordinarily high doses, ionizing radiation only raises lifetime cancer mortality rates a little bit—just two thirds of one percent for survivors who were within three kilometers of ground zero.” Few people know that low doses from a dirty bomb exposure pose little (not zero, but minimal) health risks, but rather people tend to hear “radioactive” or “nuclear radiation” and run screaming to the hills like a zombie hoard is approaching. While Ropeik points out that there will of course be devastation and economic damage, the resulting stress, fear, and public outcry for retaliation can be just as damaging. So what can we do? He points to the US Nuclear Regulatory Commission (NRC) and CDC educational sites, but emphasizes that in the end, a communication campaign to combat fear would “take at least some power of a dirty bomb to terrorize us out of the hands of the terrorists”.

Stories You May Have Missed:

  • Biosurviellance Ecosystem- The DoD and DHS are currently working on a new system that would allow epidemiologists to “scan the planet for anomalies in human and animal disease prevalence, warn of coming pandemics, and protect warfighters and others worldwide.” The Biosurveillance Ecosystem (BSVE) is a brain child that would allow epidemiologists to customize and collaborate – better yet, it’s being developed using open-source software and works “as a dashboard-like service from the cloud, accessible through an Internet browser”.
  • Select Agent Guidance– The Federal Select Agent Program (FSAP) is asking for community members to submit comments regarding the Guidance for Nonviable Select Agents and Nonfunctional Select Toxins. If you’re a member of the regulated community, help the FSAP become more transparent and strengthen biosecurity efforts! Comments will be accepted through March 14, 2016.
  • Giant Virus Secret Weapon: An Immune System – Whether it’s Frankenvirus or one of the other hundreds of giant viruses researchers have been finding, they’re teaching us a lot about secret weapons within the virus arsenal. Researchers working with a few of the giant viruses reported on Monday that some of the genes actually provide an immune system. Even crazier? The immune system “works a lot like the CRISPR system in bacteria that scientists have co-opted as a powerful gene editing tool.”

Pandora Report: 2.19.2016

by spopescu, posted in Pandora Report

TGIF! We hope you had a lovely week while avoiding RAW Meal Organic Shake and Meal Replacement products. The FDA recently reported an outbreak of Salmonella Virchow linked to the moringa powder within these products. 11 people across nine states were impacted by the outbreak, leading to an expanded recall due to the contamination. In this week’s Pandora Report, we’re covering Zika virus, CRISPR, GMU’s Biodefense Open House, ISIS use of chemical weapons, and much more. Before we begin, you’ll be happy to hear that as of today, airline passengers flying from Guinea to the US will no longer have to fly through designated airports and undergo screening for Ebola.

Zika Response Plans 
The WHO just released their Zika Strategic Response Framework & Joint Operations Plan for January-June 2016. Within the report, readers can find a timeline of the outbreak, a current situation report (sitrep) and the three objectives, which include surveillance, response, and research. Response strategies include community engagement, control efforts for the Aedes mosquito, and efforts to support and guide “the potential impact on women of childbearing age and those who are pregnant, as well as families with children affected by Zika virus.” The WHO estimates that the community engagement components requires $15.4 million, 10 partners, and will involve public health risk communication, community engagement, and health care personnel. Overall, the WHO estimates that to “kickstart” the international response, it will take $56 million. Fortunately, the World Bank announced it’s commitment of $150 million to combat the growing epidemic. The FDA just released blood donation recommendations related to the outbreak to mitigate risk of contamination. They are recommending that “those at risk of having been infected with the Zika virus should not donate blood for four weeks. These include those who have had Zika virus symptoms or sexual contact with people who have traveled to countries known to have ongoing transmissions.” According to the CDC, as of February 10th, there have been 52 travel-associated Zika virus associated cases in the US. On Thursday, Pope Francis suggested that women could justifiably use contraception to avoid pregnancy in Zika affected countries.

Upcoming Events: SPGIA Master’s Open House and Biodefense Seminar!Biodefense_320x180
Interested in furthering your education and getting to study topics like bioweapons, disease outbreaks, and terrorism? Check out the GMU Master’s Open House on Thursday, February 25th, 6:30pm at our Arlington Campus in Founder’s Hall, Room 126. Dr. Koblentz, GMU biodefense program director and one of our amazing professors, will also be holding an informational session at 7pm. You can even virtually attend if you’re looking to get more details on the biodefense graduate program and what kinds of adventures it entails. Once you’ve gotten your feet wet by attending one of the Open Houses, try our Biodefense Course Sampler on Wednesday, March 2nd, at 7pm in Founders Hall (GMU Arlington Campus), room 502. Dr. Koblentz will be hosting the event to discuss the unique challenges the US faces when it comes to global health security. Ranging from biosafety to natural disasters, and even zombies, this is a great way to get a taste of the GMU Biodefense program! Make sure to RSVP though, since space is limited.

Workshop on Women’s Health in Global Perspective
GMU’s School of Policy, Government, and International Affairs will be hosting this engaging and informational workshop on March 3, 2016 (8:45am-4:45pm), at our Arlington campus, in Founders Hall 111 and 1113. The keynote address will be from Dr. Nancy Lee, director of the Office of Women’s Health in the Department of Health and Human Services. Panels will discuss contraception and prenatal care, violence against women, dealing with disease, cross border concerns, and the role of gender disparities in women’s health outcomes. Lunch will be provided and while this event is free and open to the public, you’ll need to register here.

ISIS Use of Chemical Weapons
On Friday, CIA director John Brennan, confirmed that ISIS fighters have not only utilized chemical weapons, but also have the means and capabilities to make them. Reports indicate that ISIS is capable of making small quantities of chlorine and mustard gas. Brennan also pointed to potential exportation of chemical weapon to the West for financial incentives, noting that “there’s always a potential for that. This is why it’s so important to cut off the various transportation routes and smuggling routes they have used.” Confirmatory lab results from the Organization for the Prohibition of Chemical Weapons (OPCW) established the definitive presence of mustard gas in the attacks on Kurdish forces last year. “The OPCW will not identify who used the chemical agent. But the diplomat, speaking on condition of anonymity because the findings have not yet been released, said the result confirmed that chemical weapons had been used by Islamic State fighters. The samples were taken after the soldiers became ill during fighting against Islamic State militants southwest of Erbil, capital of Iraq’s autonomous Kurdish region.” Given their successful use of mustard gas and growing concerns over development capabilities, Brennan noted that “US intelligence is actively involved in being part of the efforts to destroy ISIS and to get as much insight into what they have on the ground inside Syria and Iraq.”

Ongoing Challenges and Future Considerations for DHS Biosurveillance Efforts 
The US Government Accountability Office (GAO) recently published their findings regarding the Department of Homeland Security’s (DHS) biosurveillance efforts, specifically the National Biosurveillance Integration Center (NBIC) and the BioWatch program. Initial findings in 2009 found that NBIC wasn’t “fully equipped to carry out its mission because it lacked key resources—data and personnel—from its partner agencies, which may have been at least partially the result of collaboration challenges it faced.” Recommendations were made and then in August 2012, NBIC released its Strategic Plan in response to the deficiencies, of which focal points included clarification of its mission and efforts to fulfill its roles of analyzer, coordinator, and innovator. Since 2012 though, GAO has noted several challenges DHS has faced in attempts to justify the BioWatch program. In 2015, “GAO found that DHS lacks reliable information about the current system’s technical capabilities to detect a biological attack, in part because in the 12 years since BioWatch’s initial deployment, DHS has not developed technical performance requirements for the system. GAO reported in September 2015 that DHS commissioned tests of the current system’s technical performance characteristics, but without performance requirements, DHS cannot interpret the test results and draw conclusions about the system’s ability to detect attacks.” Based off their findings, GAO recommended DHS not pursue the upgrades it was considering to the program. Some of the changes NBIC will be pursuing include its modification to the Daily Monitoring List  and better integration of projections and forecasts. You can find the report here, which also includes a table regarding benefits and challenges for structural changes within NBIC. Coincidentally, there was a webinar this week on “Defending Against Bioterror with Improved BioWatch Standards”. During the webinar, the presenters (Dr. Georges Benjamin and Dr. Bruce Budowle) emphasized that BioWatch is an integrated system that “needs to be used with care and caution, but it’s really a marvelous piece of technology.” They also spent time discussing how PCR results may pose problematic for end users and how BioWatch “is a good investment that should continue”.

Mental Health Challenges in Ebola Fighters
The 2014 outbreak left untold damages upon the affected countries. Unfortunately, mental health is one that may have gone unnoticed. While doctors and nurses raced to respond to the outbreak, the response to mental health was given little thought. Fighters in the Ebola battle are now fighting personal struggles with alcoholism, depression, and drug addiction. In countries that have even fewer mental health professionals than medical doctors, many are in desperate need. Some of these include young men that signed up to bury the bodies of Ebola patients in the grassy mud within Liberia. Drew Hinshaw discusses how these “burial boys” found themselves digging graves for their own children and are now left struggling to find work and are suffering from severe PTSD and the emotional effects of such an ordeal. “Liberia has just one psychiatrist for a population of four million, according to the health ministry. Sierra Leone, home to seven million, also has only one. The mental-health wing of the Liberian health ministry has just two staffers on payroll.” The truth is simple- the impact of an outbreak of this magnitude, especially within impoverished countries, has rippling effects that go on for years. Perhaps future outbreak response and preparedness models should include mental health support during and following the outbreak?

Stories You May Have Missed:

  • Future of CRISPR– CRISPR technology has been making headlines since it’s initial discovery, especially with Science naming it the Breakthrough of the Year. Its ease of use has raised many red flags for those within the science and biosecurity community. One of its discoverers, Jennifer Doudna, worked to answer questions and dispel concerns regarding mis-use, stating that “she considers it one of her responsibilities as a researcher to ensure that she educates people about the technology and listens to their questions and concerns about its use. She says one of her biggest fears is “waking up one morning and reading about the first CRISPR baby, and having that create a public backlash where people ban or regulators shut this down, and I think that could be very detrimental to the progress of the field.”
  • UK Parliament Report – Lesson Learned from Ebola – The UK Parliament has released their findings on the 2014 Ebola outbreak and the UK’s response efforts. Pointing to the necessity of strong and reliable communication, they emphasized that research must be started swiftly during such events. “The willingness of Government agencies, third sector organisations, health and aid workers, universities, and pharmaceutical companies to go above and beyond to help tackle the outbreak was phenomenal. The swift pace at which clinical trials were approved and conducted particularly stood out.” For updates on the outbreak, you can see the WHO sitrep here.
  • MERS-CoV Updates – A new report from Emerging Infectious Diseases discusses the infection of alpacas in a region where MERS-CoV is endemic. Given the susceptibility of alpacas, this could broaden the geographical distribution of potential cases. Walter Reed Army Institute of Research (WRAIR) has started a Phase 1 clinical trial (the first to be tested in humans) for a MERS-CoV vaccine.

Enjoying your weekly dose of the Pandora Report? Sign up to receive it every week so the fun never ends! 

Pandora Report 2.12.2016

by spopescu, posted in Pandora Report

This week we saw a lot of movement on the Zika response front – from increased funding to research teams prepping for field work, the outbreak hype is picking up traction as the horrors of Ebola are still fresh. Natural outbreaks aren’t the only thing drawing concern this week, as James Clapper, Director of US National Intelligence, added gene editing to the list of dangers posed by “weapons of mass destruction and proliferation.” The annual worldwide threat assessment report stated that, “research in genome editing conducted by countries with different regulatory or ethical standards than those of Western countries probably increases the risk of the creation of potentially harmful biological agents or products,”. Good news for hospital preparedness, the US Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response and the CDC have announced continued funding for the Hospital Preparedness Program (HPP). The HPP supports critical healthcare preparedness efforts in order to reduce the “supplemental state and federal resources during emergencies, and enables rapid recovery.” If you’re trying to work some biodefense into your Valentine’s Day, you’ve got a few options via Jane Austen-inspired zombie adventures in Pride and Prejudice and Zombies or episodes of The Walking Dead. Whichever zombie adventure you choose, just remember to avoid cuddling with any armadillos (read on to find out why). Happy Friday!

Lassa Fever Outbreak Grows
The Lassa fever outbreak that began hitting Nigeria in August 2015 has continued to spread, worrying many health officials. 101 people have already died from the infection and roughly 175 people have become infected. The Nigeria Centre for Disease Control (NCDC) stated, “As of today, 19 [including Abuja] states are currently following up contacts, or have suspected cases with laboratory results pending or laboratory confirmed cases.” Annually, Lassa fever causes 100,000-300,000 infections and 5,000 deaths in west Africa. Nigeria’s neighbor, Benin, is also seeing an increase in cases, in which seventeen have died and fifty have been infected.

Back Down the Zika Rabbit Hole
In response to the growing threat of Zika virus, the Obama administration announced on Monday that it would formally be requesting an emergency funding of $1.8 billion to combat the outbreak. The Department of Health and Human Services (including the CDC) would obtain the majority of the funds ($1.48 billion). CDC efforts will be ramped up as its emergency operations center was moved to a level 1 (the highest level) and teams are being coordinated to study the microcephaly-infection links. You can also check out the White House press release here. The WHO will be working to prioritize and fast-track research and development projects, of which Zika virus will be included. You can also find a great timeline here. According to the CDC, as of February 3, 2016, there were 35 travel-associated cases in the US. The Lancet also just released this piece discussing the labeling of Zika virus as a public health issue of concern.  On February 16, 2016, The National Academies of Sciences, Engineering, and Medicine are holding a workshop on research priorities to inform public health and medical practice for domestic Zika virus cases.

ASM-BiodefenseScreen Shot 2016-02-10 at 11.49.22 PM 
The 2016 American Society for Microbiology Biodefense and Emerging Diseases Research Meeting took place this week in Arlington, VA. For a biodefense fan, this was a pretty amazing three-day experience. Conference attendees were treated to presentations on antimicrobial resistance, applied biodefense, medical countermeasure developments, agroterrorism, and much more. Did I mention the keynote speaker was Dr. Tom Frieden, director of the CDC? I’m not even a little ashamed to admit how great it was to see Dr. Frieden emphasize that “nature is unpredictable but what is predictable is that we can be better prepared.” He also noted that “Zika is a rapidly changing situation” and the CDC would be sending a team within the next week to start a case-control study related to infection and microcephaly. Some highlights included getting to listen to Dr. Raymond Zilinskas discuss Russian biodefense efforts and how CBR training exercises increased in 2015. Dr. Jens Kuhn from the NIH wins the award for most humor during his fascinating presentation on Marburg and Ebola research within the Soviet bioweapons program. The infection preventionist in me greatly appreciated the session on antibiotic resistance and the role of medical tourism as an exposure for patients to CRE, not to mention how travel assists global clonal expansion. The Mayo Clinic’s Dr Tosh pointed out the short term (isolation of patients, hand hygiene, etc.), medium term (new microbial therapeutics, new diagnostics, etc.), and long term (specific pathogen therapy, decolonization, and immunologic therapy) response and control mechanisms for drug resistance. Last but not least, one of the biggest objectives from the applied biodefense presentations was the need for scientists to help inform policymakers about their work to drive the best policies. I would highly encourage anyone interested in the biodefense field to attend future conferences, as it was a wonderful learning experience and the poster/exhibitor sessions were an excellent way to learn about new research and network.

Lessons Learned: Using North Korea’s History to Better Understand Iran’s Nuclear Program
GMU biodefense professors, Dr. Thrall and Dr. Koblentz, discuss the use of North Korean nuclear history as a teaching tool regarding Iran’s nuclear program. By comparing and contrasting these two countries and their propensity for nuclear weapons, they look to similarities like the fact that both countries “are located in historically dangerous neighborhoods and face militarily superior adversaries. In North Korea’s case, South Korea and the United States; in Iran’s case, a Middle East full of Sunni Arabs and a nuclear-armed Israel. From a national security perspective, both countries have obvious reasons for pursuing a nuclear capability.” Given that both countries tend to be immune towards coercion, continued engagement and confrontation is vital. Using North Korea as a model for behavior, vigilant deterrence will be necessary to prevent Iran from cheating on the nuclear deal.

Managing Emerging Health Security Threats Since 9/11: The Role of Intelligence
Dr. Patrick F. Walsh, Associate Professor of Intelligence and Security Studies at Charles Sturt University in Australia, discusses the role of intelligence throughout the evolution of biosecurity since the 9/11 attacks. Dr. Walsh calls attention to the difficulties in defining biosecurity and that “cross-disciplinary focus is both a strength and weakness to understanding biosecurity threats. It is a weakness in that the presence of multiple players in the biosecurity field can result in a more fragmented understanding and operational response to various biosecurity threats. But it is also a strength in that, if intelligence systems are optimal, a multi-disciplinary approach allows a combination of expertise to assess and manage the bio-threat or risk.” Dr. Walsh presents the role of dual-use research, stolen biological agents, and the growing concern among biosecurity regulators and national security intelligence groups regarding the dwindling role of tacit knowledge and availability of equipment and technology. Dr. Walsh points out that the character of intelligence varies depending on the issue and one must account for the role of decision making. Lastly, he reminds us that “to conceptualize the role of intelligence in improving early warning of biosecurity threats is to examine how it can provide warning through various stages of the intelligence cycle, which includes the following stages—direction, collection, analysis, and dissemination.” While the role of intelligence will continue to evolve with biosecurity threats, Dr. Walsh emphasizes that strategic early warning capabilities are dependent upon the efficacy of intelligence framework. Improving these two facets of biodefense will allow critical infrastructure to not only respond to threats of bioterrorism and emerging infectious diseases, but also the growing threats of microbial resistance and dual-use research. You can also find the article here (2016 Walsh Health Security and Intelligence Jan).

Biosecurity in the Age of Big Data: A Conversation with the FBI
Advances in life science and technology can solve many health issues, but they can also pose a threat if used within the wrong context. Dual-use research of concern, CRISPR, and biotechnologies have led to some remarkable revolutionary advances, however, where do these fit within the FBI’s security concerns for bioweapons? Keith Kozminski of Molecular Biology of the Cell met with FBI Supervisory Special Agent (SSA) and head of the Biological Countermeasures Unit at their Washington, DC headquarters, Edward You, to discuss the security implications of Big Data. SSA You detailed his work with the American Association for the Advancement of Science and the United Nations Interregional Crime and Justice Research Institute to identify the security issues associated with Big Data when it comes to biology. Whether collaborating with companies like Amazon and IBM or government agencies like the CDC, SSA You has worked to identify potential vulnerabilities and how they can be addressed without halting innovation. SSA You states that “Over the last two years, we have had the issues with regard to the Centers for Disease Control and Prevention (CDC) and Department of Defense (DoD). A lot of discussion also came when the J. Craig Venter Institute synthesized that bacterial genome. There were a lot of calls and discussions about the scientific community needing more ethics training and the need to develop a greater culture of responsibility. From a law enforcement perspective those are necessary but not sufficient. What has been lacking is the scientific community being provided security awareness—something that augments how they approach the life sciences.” While there are vulnerabilities across the board, SSA You emphasized the need for partnership between biologists and WMD coordinators to not only safeguard science, but reduce threats.

UN- Protecting Humanity from Future Health Crises: Report of the High-level on the Global Response to Health Crises 
The UN has released an advanced copy of their report regarding global health safety. Highlighting the efforts and failures within the Ebola outbreak, this report emphasizes the global burden of communicable diseases and how better response and preparedness is needed. The report points out that only a third of the 196 State Parties have fully implemented the International Health Regulations (IHR, 2005) and there has been little global investment in R&D for emerging infectious diseases. 27 recommendations were made to address issues at the national, regional, and international levels, of which one of the first was for the WHO to build a new Centre for Emergency Preparedness and Response. The report also states that “all countries must meet the full obligations of the IHR” and “appropriate financing is required. Assistance should be provided to countries requiring additional support for IHR compliance, while WHO and the new Centre for Emergency Preparedness and Response must be resourced to meet global needs.” Overall, the use of the 2014 Ebola outbreak as a case study for health security recommendations echoes the sentiment that Dr. Frieden once noted– “a disease outbreak somewhere is a risk anywhere”

Stories You May Have Missed:

  • Vaccines & Therapeutic Conference– Mark your calendars for the 14th annual conference from May 17-19, 2016, in Washington DC, that covers biodefense, antimicrobial resistance, and emerging infectious diseases. Given the recent push for emergency funding for Zika virus research, this conference will be a great resource for up and coming research.
  • Quality Training for BSL-4 Biocontainment Laboratories– Interested in BSL-4 lab training? The FDA and University of Texas Medical Branch, Galveston National Medical Branch, will host training April 25-29, 2016. Held in Bethesda, MD, the course will include faculty and subject matter experts from the FDA, academia, and more.
  • Leprosy Spike in Florida– Florida has seen an increase in leprosy cases this year. Five cases have been reported in 2016 so far and 27 were reported in 2015. The spike in cases is suspected to be a result of armadillo transmission. If you find yourself traveling in Florida, you may want to avoid armadillo cuddling.

 

Pandora Report 1.15.2016

by spopescu, posted in Pandora Report

Welcome back to the Pandora Report! Miss us? We hope you had a lovely holiday and with so much going on in the world of biodefense, there’s not a moment to waste! Before we venture down the rabbit hole of bioweapons, outbreak response, and Ebola, here is Fun History Fact Friday: on January 12, 1965, scientists conduct a nuclear test, or what they called a “controlled excursion”, in Nevada that produced a radioactive cloud over Los Angeles, CA.

The Civil-Military Response to the 2014 Ebola Outbreak
The University of Sydney recently published the report, “Saving Lives: The Civil-Military Response to the 2014 Ebola outbreak in West Africa”. Co-authored by biodefense professor, Dr. Frank Smith III, the report discusses the international civilian response and eventual deployment of military personnel to fight the outbreak. “Strong leadership from the President and the health sector in Liberia was recognised as key to the country’s effective response, whereas weak leadership and patronage within the health sector was seen to hurt the response in Sierra Leone. Limited trust in government undermined public health, inhibiting behavioral change and social awareness campaigns (particularly in Sierra Leone).” The report includes eight recommendations that range from addressing gaps in national health systems to enhancing civilian and military response training. While many reports have focussed on civilian response, this provides actual statistics for military personnel, funds spent, PPE, military aircraft, international civilian personnel, etc. The University of Sydney summary sheds new light on the civilian and military successes and failures within outbreak response and how the 2014 Ebola outbreak revealed few organizations were truly prepared to handle a public health emergency of this magnitude.

5,300-Year-Old Gut Bacteria
Imagine you’re spending a lovely afternoon hiking and enjoying the great outdoors, when you stumble along a body in a snowfield. That’s exactly what happened to a German couple in 1991 in the Italian Alps. After days spent recovering the 5,300-year-old body (named Ötzi after the area he was found in) and 24 years worth of scientific work, researchers were able to reconstruct the genome of a bacterial species that was found in his stomach. Ötzi is unique in his level of preservation, which made this microbial discovery that much more possible. Interestingly, scientists found Helicobacter pylori (H. pylori) in Ötzi’s stomach. While H. pylori is known for causing stomach ulcers and gastric acid, it was fascinating to find that despite the bacteria being 5,3000 years old, they were “pretty much the same as ones carried by humans today.” Matching H. pylori strains from different points around the world has allowed epigeneticists to understand the introduction and transmission of certain organisms. While Ötzi was a rare find, his gut bacteria is helping researchers understand how certain strains combined and survived throughout history.

IMG_3512The Rocks – Sydney’s First Plague Sighting
During my adventures in the land down under, I couldn’t resist checking out the Rocks. A wonderful historical section of Sydney’s harbor, it’s famous for not only the preservation of buildings, but also it being the location of where the bubonic plague first broke out in Australia. Given the plague’s historical success via nautical enterprises, it’s not surprising that it would first rear its ugly head in this large harbor. Arriving in 1900, the bubonic plague was already anticipated to hit Australia, given the 1894 outbreak in Hong Kong and shipping trade routes. Officials were bracing for the outbreak when it finally reached Australian shores on January 19, 1900 via a 33-year-old delivery man by the name of Arthur Paine.

Since we’re on a history kick (and if you happened to read Greek Fire, Poison Arrows & Scorpion Bombs from our holiday reading list), you may enjoy learning about ancient Roman sanitation. While their latrine and sewage system was highly advanced, researchers have pointed out that they didn’t keep people safe from intestinal parasites and a host of other hygiene-related illnesses.

Project SHAD: Veteran Exposures to CBW Agents
A recently published report discusses the US military testing performed between 1963 and 1969 for Project SHAD (Shipboard Hazard and Defense). Project SHAD addressed naval vulnerabilities to chemical and biological weapons. “Approximately 5,900 military personnel, primarily from the Navy and Marine Corps, are reported to have been included in Project SHAD testing.” Initially disclosed in 2000, the first medical report was then released in 2007 after concerns related to veteran health. The push for further epidemiological studies prompted the 2016 report that reviewed health outcomes of the veterans that were exposed more than 50 years ago. While there are temporal limitations to the studies, they evaluate a range of concerns like frequency of exposure and reported health anomalies. With this new report, there may be future requests for research related to the US bioweapons program and its impact on those involved in field tests.

Solving the Geometrical Problem of Terrorism
GMU Biodefense PhD alum and SPGIA Distinguished Alum award recipient, Dr. Daniel M. Gerstein, discusses the components of terrorist organizations that make US response challenging. Dr. Gerstein points out that no single approach or tactic will ensure American safety, but rather that we need to see “terror organizations as being composed of four elements, organized in concentric circles with the leaders at the center bull’s eye, operational elements in the second ring, supporters in the third and sympathizers in the fourth.” By changing our outlook on terrorist organizations, separate strategies can be developed to address each unique feature and more effectively respond to terrorist threats.

One Step Closer to Ending West Africa’s Ebola Outbreak
On January 14, 2016, WHO declared “the end of the most recent outbreak of Ebola virus disease in Liberia and says all known chains of transmission have been stopped in West Africa.” This isn’t the first time Liberia has been declared free of the disease, however shortly after the country found itself with a new flare-up. Laboratory-confirmed cases soared beyond 15,000 and over 11,300 deaths have been reported in this outbreak, which is the worst since the identification of the disease. All three of the hardest hit countries (Guinea, Liberia, and Sierra Leone) have reported zero cases for two incubation periods (42 days). WHO’s Special Representative for the Ebola Response, Dr. Bruce Aylward, notes that this is the critical point in the epidemic and flare-ups are anticipated but preparedness will determine the scope and brevity of future cases. While airport screening for returned travelers from the affected regions has ceased, many health departments have encouraged hospitals to continue with their screening questions and surveillance. *Update: Sierra Leone has reported a death due to Ebola on 1/15/2016.

Stories You May Have Missed:

  • Zika Virus Outbreak Updates: Reaching Puerto Rico (bringing the total to 14 countries) and with a newly identified case in Texas (not locally acquired, but due to recent travel), the outbreak has caused almost 3,000 cases in Brazil alone. Along with the growing geographical distribution, public health officials worry about the 20-fold increase of microcephaly in infants that may be associated with Zika virus infections.
  • Burkholderia pseudomallei Concerns –Mostly found in Southeast Asian and Australian soil, a recent study predicts that B. pseudomallei could move into southern parts of the US. While not a new concern in the biodefense community, B. pseudomallei worries many as it is highly resistant to antibiotics and may be remarkably underreported.
  • What Else Is Hiding in Laboratory Freezers? Biosecurity issues aren’t new, but what else is lurking in the depths of laboratory freezers? Recent WHO warnings to clear out freezers of Rinderpest virus point to the growing concern that once eradicated diseases may rear their ugly heads via lab safety failures.

Enjoying your weekly dose of the Pandora Report? Sign up to receive it every week so the fun never ends! 

Pandora Report 12.25.2015

by spopescu, posted in Pandora Report

Happy Holidays fellow biodefense gurus! We at the Pandora Report would like to wish you and yours a lovely holiday season, filled with happiness, health, and a side of relaxation. Your favorite weekly dose of biodefense news be taking a few weeks off from reporting while I venture to the land of Oz. Rest assure, should there be a zombie outbreak, I’ll report it first hand! Since we’ll be radio silent for a couple of weeks, we’ve compiled a pretty swanky “I love biodefense and need more of it” reading list to keep you busy. Before you venture down the biodefense rabbit hole, here is fun history fact Friday: on December 24th, 1814, the war of 1812 ended and on December 24, 1936, the first radioactive isotope medicine was administered by Dr. John Lawrence. 

The Revolving Door of Biosafety7898_lores
GMU Biodefense Master’s student and lab guru, Scott McAlister discusses the importance of biosafety in the changing world of global health. Through his review of the 2009 report by the Trans-Federal Task Force on Optimizing Biosafety and Biocontainment Oversight and a 2015 memorandum released by the White House to enhance biosafety, he discusses the ever changing components of US biosafety. Scott breaks down and compares each report’s recommendations, language, and what these translate to within US laboratories. Moreover, given the recent failures, have US biosecurity practices and recommendations evolved over the past 6 years? Take a look into this review to see where we hope to be and if we’ve progressed since 2009.

National Action Plan for Combating Multidrug-Resistant TB
This week the White House released its national plan for combating the growing threat of multidrug resistant tuberculosis. While US rates of TB cases have dropped, the growing threat of multidrug resistant TB (MDR-TB) and extensively resistant TB (XDR-TB) requires action. This new plan is set to span over 3-5 years and has three goals that will focus on strengthening domestic capacity, improving international capacity and collaboration, and accelerating basic and applied research and development. Extensive collaboration within US agencies and international partners will be necessary to combat the evolving threat of drug resistant tuberculosis.

We’re Not Prepared for a Biological Attack
GMU Biodefense PhD alum, Dr. Daniel M. Gerstein, discusses biopreparedness and where the US stands in his work for US News  & World Report. Throughout his in-depth analysis, Dr. Gerstein emphasizes the importance of US leadership within the Biological Weapons Convention (BWC). Pointing to the disappointing Seventh and Eighth Review Conferences, Dr. Gerstein notes, “biological warfare can no longer be considered the purview of only state actors. And this democratization of biotechnology means that the world is literally one rogue microbiologist away from a potentially devastating biological attack.” Dr. Gerstein emphasizes that authorities often fail to realize that biological weapons may not act like naturally occurring diseases or outbreaks.

Holiday Biodefense Book Club
During the cold winter months it’s always nice to curl up by the fire with a good book and relax. GMU Biodefense Master’s student, Rebecca Earnhardt, and I have picked a handful of books to spark your interest. If we could have a book club with our awesome readers, we would love it, but in the mean time, here are our recommendations for a few literary works that you might enjoy!

  • Phantom Menace or Looming Danger?: A New Framework for Assessing Bioweapons Threats By Kathleen M. Vogel — Johns Hopkins Press, 2012. The military has gathered reconnaissance of a possible biological research facility, evidence of a paper trail indicating procurement of weapons delivery systems, and collection of specialized personnel to manufacture biological agents.  Do all of these pieces point to an imminent biological weapons danger?  Kathleen M. Vogel, in Phantom Menace, argues that there is more to the picture of biological weapons development than the technical and physical aspects of manufacturing.  Through examination of three case studies, Vogel highlights the shortcomings of the dominant biotech revolution frame within biological weapons assessments.  The biotech revolution frame, as described by Vogel, misses the important social and contextual factors that affect biological weapons innovation.  The alternative offered by Vogel is termed the biosocial frame.  Vogel highlights in her biosocial frame how tacit knowledge and hands-on experience is vital to biological weapons assessments.  While Vogel does not particularly focus on political influences, I enjoyed the book because of her explanation of the importance in incorporating sociological aspects into biological weapons assessments.  I think this makes Vogel’s work a key book in the field of biodefense.
  • Innovation, Dual Use, and Security: Managing the Risks of Emerging Biological and Chemical Technologies. Editor: Jonathan B. Tucker — MIT Press, 2012. The hotly debated concept of ‘dual-use’ is explored extensively through this multipart work edited by the late chemical and biological weapons expert, Jonathan B. Tucker.  This book takes on the conceptual nuances of dual-use with four parts focused on emerging technologies within the areas of directed design, acquisition of novel molecular parts, modification of biological systems, and enhanced production and packaging capabilities.  Each section, authored by leading experts in the field of biodefense research, including Filippa Lentzos and Gerald Epstein, applied Tucker’s framework of risk assessment for dual-use potential and governability.  This framework incorporates key aspects of assessing dual-use potential, including technological monitoring, technology assessments, and governability of the technology.  The strength of this framework lies in its applicability to emerging technologies, which may enable policy makers to continuously review a particular technology or an emerging area of research.  In the concluding chapter, Kirk Bansak and Jonathan Tucker redirect attention to the intervening social processes that construct relationships between the technology and its users, and how these social processes may create an environment ripe for misuse.  To me, this book is a highly valuable and informative work on the range of dual-use issues and conceptual applications.  I think this book is an important read not only because it covers a variety of dual-use issues, but also in its wide-ranging review of relatively recent biotechnology and life science innovations.  The variety of case studies makes this book an enjoyable read!
  • Spillover: Animal Infections and the next Human Pandemic by David Quammen. New York: W.W. Norton, 2012. Not only is David Quammen one of my favorites, but his overview of zoonotic diseases and the concept of spillover will both captivate and inform you. Ranging from West Nile Virus to Ebola, Quammen presents several of the zoonotic diseases you may have heard of and others that may cause you to reconsider kissing a horse anytime soon. Each chapter presents a new disease, it’s history, and a new outbreak that should raise our attention to global health security. While he doesn’t touch much on avian influenza or multi-drug resistant organisms, his points on humans infringing upon animal ecosystems and the resulting disease spillovers are harrowing. Quammen’s adventures remind me of a microbial Indiana Jones (hint hint Hollywood, that would make an excellent movie!), even with the cheeky wit. I would recommend Spillover as a gateway to understanding the role of zoonotic diseases and the emphasis we’re seeing on One Health. While his parts on Ebola aren’t as dramatic as Richard Preston, you’ll be sure to enjoy his approach to epidemiology and the impact of spillover on global health. Quammen did extend his sections on Ebola into another book that includes information related to the 2014/2015 outbreak. If you enjoy on-the-ground reporting, you’ll find this within Quammen’s book.
  • Greek Fire, Poison Arrows, and Scorpion Bombs: Biological and Chemical Warfare in the Ancient World by Adrienne Mayor. Woodstock: Overlook Duckworth, 2003. As a lover of all things biodefense and classical, I was excited when I cam across Adrienne Mayor’s book. Combining ancient history and bioweapons? Sold! Mayor’s breakdown throughout the book reveals the mythical and historical accounts of chemical and biological weapons in the ancient world. While a bit dramatic and sometimes repetitive, I found her book to be enjoyable in that few people have combined ancient history and chem/bioweapons to such an extent. Mayor makes sure to include references to mythology that heavily impact these ancient societies. While the lines of chemical and biological weapons were sometimes muddied and some generalizations related to classical history did occur, I would recommend her book to anyone who enjoys history (especially ancient history), mythology, and CBW. Realistically, with such a catchy title, how could you resist?

Stories You May Have Missed:

Pandora Report: 12.18.2015

by spopescu, posted in Pandora Report

Hungry, hungry anthrax hippos? If there’s one thing we love about the science community, it’s when a gem pops up in your inbox like this (thanks ProMed!). In Ebola news, public health officials are exploring the possibility that survivors may be a potential source of case surges. Fun history fact Friday: On December 18, 1620, the Mayflower docked at Plymouth Harbor and passengers began settlement and on December 14, 1980, the CIA issued a warning about Soviet arms sales to Third World nations. Take a break from holiday preparations with this week’s Pandora Report – we’re discussing everything from zombies to Bob Dylan lyrics!

Epidemiology of a Zombie Outbreak
Tara C Smith and the writers of The BMJ certainly know how to hook a biodefense nerd – epidemiology of zombie infections? Don’t mind if we do! Using historical tales and movie outbreaks, Smith takes us through several hypothetical zombie outbreaks we’ve experienced as viewers or readers for the past few decades. Tracing the origins of certain outbreaks and the transmission patterns via bite, this scientific approach to one of our favorite topics is fascinating.  Potential etiological considerations included weaponized Yersinia pestis, a mutation of bovine spongiform encephalopathy, or a genetically modified form of the Ebola virus that was tested on chimpanzees (that later escaped!). Last but not least, we can’t forget to consider the ethical implications of such an outbreak. How do we handle resource depletion or quarantine? All things to consider before the zombie apocalypse!

Risk & Benefit Analysis of Gain of Function Research 
With the National Science Advisory Board for Biosecurity (NSABB) meeting fast approaching (January 7-8, 2016!), we’re recapping the role of gain-of-function (GoF) research in biodefense. Earlier this year, Gryphon Scientific was awarded a NIH contract related to assessment of GoF research and the risk-versus-benefits that may impact future federal funding. With the intent to make future recommendations, the assessment had three major tasks: a risk analysis (RA) of accidents and natural disasters, a biosecurity RA, and a benefit assessment. Extensive review and analysis of data from the intelligence and law enforcement community reviewed potential gaps within security practices. “The biosecurity RA is delivered in two parts because risks posed by malicious acts targeting laboratories that conduct GoF required a different analytical approach than the assessment of the risk generated by the misuse of published GoF research.” GMU Biodefense alum and previous Pandora Report editor, Julia Homstad, is also the lead author on Chapter 11 (Risk of Loss of Trust in Science). Perhaps one of my favorite points from the report was that “this assessment requires the identification of scientific and non-scientific barriers to the realization of these benefits.” You can also find Michael Selgelid’s White Paper regarding the ethical implications of GoF research. While the 1,001 pages may seem a daunting task, this is not only a highly relevant report, but approaches GoF concerns and risks in an engaging and holistic manner.

Bob Dylan Lyrics in Medical Literature?
Have you ever read a scientific article and felt a complete unknown, like a rolling stone? Scientists at the Karolinska Institute in Sweden have been sneaking Bob Dylan song lyrics into their papers as part of a long-standing bet since 1997. “It all started in 1997 with a review in Nature Medicine entitled ‘Nitric oxide and inflammation: the answer is blowing in the wind.'” Carl Gornitzki and colleagues from The BMJ decided to do some additional digging in Medline and found that 213 of 727 found references were unequivocally citing Bob Dylan. Starting a few years after his musical debut, research papers included a variety of biomedical topics, like those of Hermanson et al., who managed to work “like a rolling stone” into their paper on epigenetics. The variety of lyrics found throughout the literature is certainly more than a simple twist of fate.

Outbreak Preparedness 2015 Report
Ever wonder how your state ranks in terms of emerging infectious disease preparedness? Trust for America’s Health and the Robert Wood Johnson Foundation recently published their 2015 report regarding state capabilities to protect against new infectious disease threats (MERS-CoV, multi-drug resistant organisms, etc.) and “resurging illnesses like whooping cough, tuberculosis, and gonorrhea.” The report found that over half of US states ranked at five or lower on a scale of ten. The five all-star states (scoring eight) were Delaware, Kentucky, Main, New York, and Virginia (go Virigina!). The report findings noted that “the nation must redouble efforts to protect Americans” and included points on healthcare-associated infections, flu vaccination rates, food safety, and superbugs. Check out the report to find where your state ranked!

Fighting Antibiotic Resistance in the United States18170_lores
On Thursday, the House Appropriations Committee presented the 2016 Omnibus Appropriations bill, which revealed discretionary funding plans for the federal government. Buried in new legislation, the FDA and NIH will receive part of this discretionary funding to help fight antibiotic resistant bacteria and “advance prevision medicine initiatives”. The FDA is set to receive $2.7 billion, which was over a $10 million increase from FY2015. Within the bill, there is “funding for the Combating Antibiotic Resistance Bacteria (CARB) initiative ($8,732,000), the precision medicine initiative ($2,392,000), and the Orphan Product Development Grants Program ($2,500,000). The NIH will receive an extra $2 billion for FY2016, which supported projects specially for Alzheimer’s diseases research, brain research, antibiotic resistance, the Precision Medicine Initiative, etc. Given last week’s report on the phantom menace CRE and growing cases of multi-drug resistant organisms, it’s extremely important antibiotic resistance be given more attention.

Stories You May Have Missed:

  • CDC Establishing Flu Vaccine Efficacy Lab Network – The CDC has provided funding for a network of US institutions to collect and analyze information related to annual flu vaccine effectiveness. “Participating institutions will coordinate enrollment of patients with acute respiratory illness, confirm influenza infection using a standardized reverse-transcription PCR (RT-PCR) assay, and estimate vaccine effectiveness.” The 30 million dollar funded project will run from July 2016-2021.
  • Avian Influenza in France – France has reported 30 outbreaks of avian influenza, specifically one of the highly pathogenic influenza. Unfortunately the strain in the most recent cases hasn’t been identified, but these outbreaks been attributed to one of the H5 strains.
  • Hawaiian Dengue Outbreak Update – Cases of dengue virus on Hawaii Island have now reached 157. There are 7 individuals considered still infectious and the Hawaii Department of Health (HDOH) continues their efforts to identify cases and reduce transmission. 140 of the cases are Hawaii Island residents, and 34 of the overall cases have been children under the age of 18.

Enjoying your weekly dose of the Pandora Report? Sign up to receive it every week so the fun never ends!